TY - JOUR
T1 - Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 : a systematic analysis for the Global Burden of Disease Study
AU - Global Burden of Disease Cancer Collaboration, Collaboration
AU - Fitzmaurice, Christina
AU - Akinyemiju, Tomi F.
AU - Al Lami, Faris Hasan
AU - Alam, Tahiya
AU - Alizadeh-Navaei, Reza
AU - Allen, Christine
AU - Alsharif, Ubai
AU - Alvis-Guzman, Nelson
AU - Amini, Erfan
AU - Anderson, Benjamin O.
AU - Aremu, Olatunde
AU - Artaman, Al
AU - Asgedom, Solomon Weldegebreal
AU - Assadi, Reza
AU - Atey, Tesfay M.
AU - Avila-Burgos, Leticia
AU - Awasthi, Ashish
AU - Ba Saleem, Huda Omer
AU - Barac, Aleksandra
AU - Bennett, James R.
AU - Bensenor, Isabela M.
AU - Bhakta, Nickhill
AU - Brenner, Hermann
AU - Cahuana-Hurtado, Lucero
AU - Castañeda-Orjuela, Carlos A.
AU - Catalá-López, Ferrán
AU - Choi, Jee-Young Jasmine
AU - Christopher, Devasahayam Jesudas
AU - Chung, Sheng-Chia
AU - Curado, Maria Paula
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - Neves, José das
AU - Dey, Subhojit
AU - Dharmaratne, Samath D.
AU - Doku, David Teye
AU - Driscoll, Tim R.
AU - Dubey, Manisha
AU - Ebrahimi, Hedyeh
AU - Edessa, Dumessa
AU - El-Khatib, Ziad
AU - Endries, Aman Yesuf
AU - Fischer, Florian
AU - Force, Lisa M.
AU - Foreman, Kyle J.
AU - Gebrehiwot, Solomon Weldemariam
AU - Gopalani, Sameer Vali
AU - Grosso, Giuseppe
AU - Gupta, Rahul
AU - Gyawali, Bishal
AU - Hamadeh, Randah Ribhi
AU - Hamidi, Samer
AU - Harvey, James
AU - Hassen, Hamid Yimam
AU - Hay, Roderick J.
AU - Hay, Simon I.
AU - Heibati, Behzad
AU - Hiluf, Molla Kahssay
AU - Horita, Nobuyuki
AU - Hosgood, H. Dean
AU - Ilesanmi, Olayinka S.
AU - Innos, Kaire
AU - Islami, Farhad
AU - Jakovljevic, Mihajlo B.
AU - Johnson, Sarah Charlotte
AU - Jonas, Jost B.
AU - Kasaeian, Amir
AU - Kassa, Tesfaye Dessale
AU - Khader, Yousef Saleh
AU - Khan, Ejaz A.
AU - Khan, Gulfaraz
AU - Khang, Young-Ho
AU - Khosravi, Mohammad Hossein
AU - Khubchandani, Jagdish
AU - Kopec, Jacek A.
AU - Kumar, G. Anil
AU - Kutz, Michael
AU - Lad, Deepesh Pravinkumar
AU - Lafranconi, Alessandra
AU - Lan, Qing
AU - Legesse, Yirga
AU - Leigh, James
AU - Linn, Shai
AU - Lunevicius, Raimundas
AU - Majeed, Azeem
AU - Malekzadeh, Reza
AU - Malta, Deborah Carvalho
AU - Mantovani, Lorenzo G.
AU - McMahon, Brian J.
AU - Meier, Toni
AU - Melaku, Yohannes Adama
AU - Melku, Mulugeta
AU - Memiah, Peter
AU - Mendoza, Walter
AU - Meretoja, Tuomo J.
AU - Mezgebe, Haftay Berhane
AU - Miller, Ted R.
AU - Mohammed, Shafiu
AU - Mokdad, Ali H.
AU - Moosazadeh, Mahmood
AU - Moraga, Paula
AU - Mousavi, Seyyed Meysam
AU - Nangia, Vinay
AU - Nguyen, Cuong Tat
AU - Nong, Vuong Minh
AU - Ogbo, Felix Akpojene
AU - et al, null
PY - 2018
Y1 - 2018
N2 - Importance: The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. Objective: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. Evidence Review: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. Findings: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallest increase was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause of cancer deaths and DALYs was breast cancer (1.7 million incident cases, 535"¯000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. Conclusions and Relevance: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.
AB - Importance: The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. Objective: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. Evidence Review: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. Findings: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallest increase was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause of cancer deaths and DALYs was breast cancer (1.7 million incident cases, 535"¯000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. Conclusions and Relevance: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.
KW - World health
KW - cancer
KW - epidemiology
KW - health surveys
UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:50858
U2 - 10.1001/jamaoncol.2018.2706
DO - 10.1001/jamaoncol.2018.2706
M3 - Article
SN - 2374-2445
SN - 2374-2437
VL - 4
SP - 1553
EP - 1568
JO - JAMA Oncology
JF - JAMA Oncology
IS - 11
ER -
